Clovis Oncology reported $9.41M in Cost of Sales for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Abbvie ABBV:US $ 4021M 259M
Acadia Pharmaceuticals ACAD:US $ 2.95M 0.39M
Acorda Therapeutics ACOR:US $ 5.97M 1.77M
Agenus AGEN:US $ 543K 338K
Anika Therapeutics ANIK:US $ 14.89M 2.8M
AstraZeneca AZN:LN 2279M 790M
Astrazeneca AZN:US 2.28B 790M
Clovis Oncology CLVS:US $ 9.41M 0.32M
Eli Lilly And LLY:US $ 2072.1M 21.9M
Esperion Therapeutics ESPR:US $ 7.12M 2.05M
GlaxoSmithKline GSK:LN 3645M 30M
Halozyme Therapeutics HALO:US $ 15.92M 5.66M
Heron Therapeutics HRTX:US $ 11.36M 0.41M
Insmed INSM:US $ 12.19M 1.1M
Intrexon XON:US $ 17.1M 2.17M
Ligand Pharmaceuticals LGND:US $ 4.7M 7.28M
Merk MRK:US $ 5334M 1507M
Neurocrine Biosciences NBIX:US $ 4.6M 0.5M
Novartis NOVN:VX SF 3755M 245M
Pfizer PFE:US $ 10010M 399M
Puma Biotechnology PBYI:US $ 10.84M 1.05M
Rigel Pharmaceuticals RIGL:US $ 0.12M 0.37M
Seattle Genetics SGEN:US $ 87.63M 0.94M
Ultragenyx Pharmaceutical RARE:US $ 6.1M 2.59M
Veracyte VCYT:US $ 23.71M 0.83M
YTE INCY:US $ 37.21M 1.36M